These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 25198231)

  • 61. The Effects of Glucocorticoid on Tendon and Tendon Derived Cells.
    Dean BJ; Carr AJ
    Adv Exp Med Biol; 2016; 920():239-46. PubMed ID: 27535266
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The risks and benefits of glucocorticoid treatment for tendinopathy: a systematic review of the effects of local glucocorticoid on tendon.
    Dean BJ; Lostis E; Oakley T; Rombach I; Morrey ME; Carr AJ
    Semin Arthritis Rheum; 2014 Feb; 43(4):570-6. PubMed ID: 24074644
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The expression of substance P and calcitonin gene-related peptide is associated with the severity of tendon degeneration in lateral epicondylitis.
    Han SH; Kim HK; Jang Y; Lee HH; Rhie J; Han D; Oh J; Lee S
    BMC Musculoskelet Disord; 2021 Feb; 22(1):210. PubMed ID: 33612098
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cardiopulmonary and Neurologic Dysfunctions in Fibrodysplasia Ossificans Progressiva.
    Khan F; Yu X; Hsiao EC
    Biomedicines; 2021 Feb; 9(2):. PubMed ID: 33562570
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Crosstalk between neuropeptides SP and CGRP in regulation of BMP2-induced bone differentiation.
    Tuzmen C; Campbell PG
    Connect Tissue Res; 2018 Dec; 59(sup1):81-90. PubMed ID: 29745819
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Crosstalk between substance P and calcitonin gene-related peptide during heterotopic ossification in murine Achilles tendon.
    Tuzmen C; Verdelis K; Weiss L; Campbell P
    J Orthop Res; 2018 May; 36(5):1444-1455. PubMed ID: 29227562
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Role of VEGF, Nitric Oxide, and Sympathetic Neurotransmitters in the Pathogenesis of Tendinopathy: A Review of the Current Evidences.
    Vasta S; Di Martino A; Zampogna B; Torre G; Papalia R; Denaro V
    Front Aging Neurosci; 2016; 8():186. PubMed ID: 27555817
    [TBL] [Abstract][Full Text] [Related]  

  • 68. What understanding tendon cell differentiation can teach us about pathological tendon ossification.
    Magne D; Bougault C
    Histol Histopathol; 2015 Aug; 30(8):901-10. PubMed ID: 25851144
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The effects of substance P on pluripotent tendon cells: an in vitro and in vivo study.
    Zhou B; Zhou Y; Tang K
    J Musculoskelet Neuronal Interact; 2014 Sep; 14(3):349-58. PubMed ID: 25198231
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The effects of substance p on tendinopathy are dose-dependent: an in vitro and in vivo model study.
    Zhou Y; Zhou B; Tang K
    J Nutr Health Aging; 2015 May; 19(5):555-61. PubMed ID: 25923486
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Substance P accelerates hypercellularity and angiogenesis in tendon tissue and enhances paratendinitis in response to Achilles tendon overuse in a tendinopathy model.
    Andersson G; Backman LJ; Scott A; Lorentzon R; Forsgren S; Danielson P
    Br J Sports Med; 2011 Oct; 45(13):1017-22. PubMed ID: 21540192
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Presence of substance P and the neurokinin-1 receptor in tenocytes of the human Achilles tendon.
    Andersson G; Danielson P; Alfredson H; Forsgren S
    Regul Pept; 2008 Oct; 150(1-3):81-7. PubMed ID: 18394729
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Sustained Exposure of Substance P Causes Tendinopathy.
    Oh SY; Kim DK; Han SH; Lee HH; Jeong Y; Baek M; Kim H; Ahn W; Lee S
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33207770
    [TBL] [Abstract][Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.